Chris Middendorf Discusses Drug Tariff Impact on NPR

He highlighted the complexity and critical regulatory demands of reshoring drug manufacturing, emphasizing that building facilities is just the beginning—rigorous qualification and ongoing compliance are essential to ensure patient safety.

Hear the full NPR report here.